Rousselot has announced the development of the SiMoGel concept for centre-filled gummies.
With this development, brands can develop centre-filled soft-gummies with the ability to include a broad range of nutrients at adequate dosage. The features of this dosage form will be detailed in Rousselot’s showcase presentation on the Fi Connect 2020 platform on 25th November at 3-3:30 PM CET.
Beyond being a popular choice for children, Rousselot says, gummy products have been shown to appeal to 65% of adults, highlighting their potential as a delivery form for nutraceutical and active pharmaceutical ingredients across different ages and needs. Adding a liquid filling can also further boost the palate experience and expand the dosing possibilities of these products, the company adds. However, producing centre-filled functional gummies with a variety of nutrients or APIs efficiently and economically can be complex.
“Bridging the gap between the appealing gummy delivery format and the RDI dosages required for nutraceuticals or APIs has long been a complex challenge for producers”, said Marit van der Heijden, Global Marketing Manager, Rousselot. “With the new SiMoGelTM concept for creating innovative center-filled gummy applications, we can help our customers to successfully tackle this obstacle. This supports our partners in creating premium center-filled gummies with a larger range of nutraceuticals or active pharmaceutical ingredients in higher concentrations, allowing them to differentiate their offering and meet the sophisticated expectations of today’s discerning consumers.”
SiMoGel enables the production of nutraceutical and pharmaceutical soft gummies in optimal conditions. With SiMoGel, the traditional starch moguls are replaced by silicone moguls or blisters. The starchless depositing, which can be done in either flexible silicone or metal molds, or directly in blister packs, prevents cross-contamination of ingredients. This technique also enhances application possibilities in terms of shape and texture.
